Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT00094822). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the same-day dosing of Neulasta® compare to the standard next-day dosing?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT00094822). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from the chemotherapy and Neulasta®?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT00094822). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT00094822). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT00094822). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT00094822). Contact the study team or your healthcare provider for specific answers.

What this study is about